Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3317, doi. 10.1111/1759-7714.15123
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 31
Results: 14
1
2
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3245, doi. 10.1111/1759-7714.14519
- Publication type:
- Article
3
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first‐line tyrosine kinase inhibitors: A single‐center ambispective cohort study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3147, doi. 10.1111/1759-7714.15108
- By:
- Publication type:
- Article
4
Prognostic and predictive impact of molecular tumor burden index in non‐small cell lung cancer patients.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3097, doi. 10.1111/1759-7714.15098
- By:
- Publication type:
- Article
5
Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3069, doi. 10.1111/1759-7714.15094
- By:
- Publication type:
- Article
6
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3140, doi. 10.1111/1759-7714.15107
- By:
- Publication type:
- Article
7
Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3161, doi. 10.1111/1759-7714.15104
- By:
- Publication type:
- Article
8
Extracellular shuttling miR‐21 contributes to esophageal cancers and human umbilical vein endothelial cell communication in the tumor microenvironment and promotes tumor angiogenesis by targeting phosphatase and tensinhomolog.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3119, doi. 10.1111/1759-7714.15103
- By:
- Publication type:
- Article
9
Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3108, doi. 10.1111/1759-7714.15099
- By:
- Publication type:
- Article
10
Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3133, doi. 10.1111/1759-7714.15106
- By:
- Publication type:
- Article
11
Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3166, doi. 10.1111/1759-7714.15105
- By:
- Publication type:
- Article
12
Paclitaxel promotes mTOR signaling‐mediated apoptosis in esophageal cancer cells by targeting MUC20.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3089, doi. 10.1111/1759-7714.15091
- By:
- Publication type:
- Article
13
Nivolumab as maintenance therapy following platinum‐based chemotherapy in EGFR‐mutant lung cancer patients after tyrosine kinase inhibitor failure: A single‐arm, open‐label, phase 2 trial.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3080, doi. 10.1111/1759-7714.15083
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 31, p. 3067, doi. 10.1111/1759-7714.14517
- Publication type:
- Article